Pasi A. Jänne, Willemijn S.M.E. Theelen, Marina Chiara Garassino, Alexander I. Spira, Janessa J. Laskin, Filippo de Marinis, Firas Benyamine Badin, Lisenka Boom, Carlos Aguado De La Rosa, Izabela Chmielewska, Enriqueta Felip, Gyula Ostoros, Lauren Jimenez-Kurlander, Cassie M. Lane, Archie Sachdeva, Laura Eccles, Shun Lu. "First-line adagrasib (ADA) with pembrolizumab (PEMBRO) in patients (pts) with advanced/metastatic KRAS
            <sup>G12C</sup>
            -mutated non-small cell lung cancer (NSCLC) from the phase 2 portion of the KRYSTAL-7 study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.8500